GLGLENVIEW CAPITAL MANAGEMENT, LLC

Institutional investor · Portfolio as of Q3 2019

Top Holdings49 positions

Checking export access…
Activity:

THE CIGNA GROUP

5.1M$779M8.2%$157.88-13.53%
4 qtrssince 2018-Q4
Increased
65

HCA HEALTHCARE INC

5.3M$643.1M6.8%$117.03-3.47%
4 qtrssince 2018-Q4
Increased
66

MCKESSON CORP

4M$547.3M5.8%$105.01+23.63%
4 qtrssince 2018-Q4
Decreased
0

IQVIA HLDGS INC

3.6M$540.4M5.7%$113.91+30.15%
4 qtrssince 2018-Q4
Decreased
0
TAKTAK
ADR

TAKEDA PHARMACEUTICAL CO LTD

27.4M$472M5.0%$18.94-14.29%
3 qtrssince 2019-Q1
Increased
61

TENET HEALTHCARE CORP

19.5M$430.8M4.5%$17.54+26.08%
4 qtrssince 2018-Q4
Increased
63
HOLXHOLXDelisted

HOLOGIC INC

8.2M$414.5M4.4%$41.07+20.78%
4 qtrssince 2018-Q4
Decreased
0

HUMANA INC

1.6M$408.9M4.3%$250.99-4.22%
4 qtrssince 2018-Q4
Decreased
0

FMC CORP

4.3M$375.6M4.0%$52.60+36.80%
4 qtrssince 2018-Q4
Decreased
0

DXC TECHNOLOGY CO

11.8M$348M3.7%$51.14-43.76%
4 qtrssince 2018-Q4
Increased
63

BAUSCH HEALTH COS INC

13.8M$301.8M3.2%$21.01+3.31%
4 qtrssince 2018-Q4
Increased
77

FISERV INC

2.7M$281.5M3.0%$102.610.00%
1 qtr
New
81

ALPHABET INC

220,434$269.2M2.8%$51.94+17.14%
4 qtrssince 2018-Q4
Decreased
0

DISNEY WALT CO

1.9M$244.6M2.6%$124.23+1.59%
3 qtrssince 2019-Q1
Decreased
0

ELEVANCE HEALTH INC

868,027$208.4M2.2%$239.14-9.02%
4 qtrssince 2018-Q4
Decreased
0

FLEX LTD

19.3M$202.4M2.1%$6.17+26.78%
4 qtrssince 2018-Q4
Increased
53

DAVITA INC

3.2M$184.7M1.9%$55.43+1.61%
3 qtrssince 2019-Q1
Unchanged
0

WILLIAMS COS INC

7.5M$181.5M1.9%$14.64+17.01%
4 qtrssince 2018-Q4
Increased
50
CBSCBSDelisted

CBS CORP NEW

4.1M$167.1M1.8%——
4 qtrssince 2018-Q4
Decreased
0

LYONDELLBASELL INDUSTRIES N

1.8M$158.1M1.7%$54.01+9.16%
4 qtrssince 2018-Q4
Decreased
0
$9.5B
AUM
49
Positions
Q3 2019
Filing
HI score · 3.0/5
Quarterly 13F Value Change
+9%Q1'19$11.2B-2%Q2'19$11B-14%Q3'19$9.5B
Activity profile
$ moved · Q3'19
New21%Increased16%Decreased43%Exited20%
Composition
Equity vs derivatives
Equity100%Puts0%Calls0%
Holding period
Avg 2.2 quarters
<1Q16%1-4Q84%1-2Y0%2Y+0%

GLENVIEW CAPITAL MANAGEMENT, LLC manages $9.5B across 49 positions as of Q3 2019. Top holdings: CI (8.2%), HCA (6.8%), MCK (5.8%). Fund DNA: Balanced Allocator. HoldingsIntel Score: 3/5.0.

Q3 2019 Summary

Active quarter - 9 new positions, 6 exits, 14 increased. Top move: FISV (NEW, conviction 81). Portfolio: $9.5B across 49 positions.

Top holdings by portfolio weight

Total AUM$10B
CI8.19%
HCA6.77%
MCK5.76%
IQV5.69%
TAK4.97%
THC4.53%
HOLX4.36%
HUM4.30%
FMC3.95%
DXC3.66%
Other3.17%

Portfolio allocation by GICS sector

Sectors9
Healthcare60.37%
Unknown11.60%
Technology7.96%
Basic Materials6.87%
Communication Services6.58%
Industrials3.17%
Energy1.91%
Consumer Cyclical1.09%
Consumer Defensive0.47%

Behavioral investing profile

Checking access…
Balanced Allocator- primarily Healthcare, Unknown
Compare DNA across all funds
7-dimension, SEC 13F-derived research score
Solid(3.0 / 5.0)
Holdings P&L67
Conviction48
Concentration88
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

Security
5Q
GPNGPNGLOBAL PMTS INC
Q2 2025 → Q2 2026+5.1M shares+$274.8M
4Q
AMZNAMZNAmazon.com, Inc.
Q3 2025 → Q2 2026+708,813 shares+$179.6M
4Q
EYEEYENATIONAL VISION HLDGS INC
Q3 2025 → Q2 2026+2.3M shares+$40.3M
Checking access…

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Verify source filings on SEC EDGAR

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used